α-Tubulin acetylation on lysine 40 controls cardiac glucose uptake

Am J Physiol Heart Circ Physiol. 2022 Jun 1;322(6):H1032-H1043. doi: 10.1152/ajpheart.00664.2021. Epub 2022 Apr 29.

Abstract

Our group previously demonstrated that an excess of nutrients, as observed in diabetes, provokes an increase in cardiac protein acetylation responsible for a reduced insulin-stimulated translocation of the glucose transporter GLUT4 to the plasma membrane. The acetylated proteins involved in this event have yet not been identified. α-Tubulin is a promising candidate as a major cytoskeleton component involved, among other things, in the translocation of GLUT4-containing vesicles from their intracellular pools toward the plasma membrane. Moreover, α-tubulin is known to be acetylated, Lys40 (K40) being its best characterized acetylated residue. The present work sought to evaluate the impact of α-tubulin K40 acetylation on cardiac glucose entry, with a particular interest in GLUT4 translocation. First, we observed that a mouse model of high-fat diet-induced obesity presented an increase in cardiac α-tubulin K40 acetylation level. We next showed that treatment of insulin-sensitive primary cultured adult rat cardiomyocytes with tubacin, a specific tubulin acetylation inducer, reduced insulin-stimulated glucose uptake and GLUT4 translocation. Conversely, decreasing α-tubulin K40 acetylation by expressing a nonacetylable dominant form of α-tubulin (mCherry α-tubulin K40A mutant) remarkably intensified insulin-induced glucose transport. Finally, mCherry α-tubulin K40A expression similarly improved glucose transport in insulin-resistant cardiomyocytes or after AMP-activated protein kinase activation. Taken together, our study demonstrates that modulation of α-tubulin K40 acetylation level affects glucose transport in cardiomyocytes, offering new putative therapeutic insights regarding modulation of glucose metabolism in insulin-resistant and diabetic hearts.NEW & NOTEWORTHY Acetylation level of α-tubulin on K40 is increased in the heart of a diet-induced mouse model of type 2 diabetes. Pharmacological stimulation of α-tubulin K40 acetylation lowers insulin-mediated GLUT4 vesicles translocation to the plasma membrane, reducing glucose transport. Expressing a nonacetylable dominant form of α-tubulin boosts glucose uptake in both insulin-sensitive and insulin-resistant cardiomyocytes.

Keywords: GLUT4; acetylation; cardiac metabolism; glucose uptake; tubulin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Acetylation
  • Animals
  • Diabetes Mellitus, Type 2* / metabolism
  • Glucose Transport Proteins, Facilitative / metabolism
  • Glucose Transporter Type 4 / metabolism
  • Glucose* / metabolism
  • Insulin / metabolism
  • Insulin / pharmacology
  • Lysine / metabolism
  • Mice
  • Myocytes, Cardiac* / metabolism
  • Protein Transport
  • Rats
  • Tubulin* / metabolism

Substances

  • Glucose Transport Proteins, Facilitative
  • Glucose Transporter Type 4
  • Insulin
  • Tubulin
  • AMP-Activated Protein Kinases
  • Glucose
  • Lysine

Associated data

  • figshare/10.6084/m9.figshare.17026496
  • figshare/10.6084/m9.figshare.17026436